Cargando…
The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ (null) Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab
BACKGROUND: To date, responsiveness to tumor necrosis factor alpha inhibitors in ulcerative colitis (UC) patients is not predictable. This is partially due to a lack of understanding of the underlying inflammatory processes. The aim of this study was to identify immunological subgroups of patients w...
Autores principales: | Jodeleit, Henrika, Caesar, Janina, Villarroel Aguilera, Christina, Sterz, Sebastian, Holdt, Lesca, Beigel, Florian, Stallhofer, Johannes, Breiteneicher, Simone, Bartnik, Eckart, Siebeck, Matthias, Gropp, Roswitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054775/ https://www.ncbi.nlm.nih.gov/pubmed/31782956 http://dx.doi.org/10.1093/ibd/izz284 |
Ejemplares similares
-
Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγ(null) mice reconstituted with human peripheral blood mononuclear cells
por: Jodeleit, Henrika, et al.
Publicado: (2021) -
Targeting ulcerative colitis by suppressing glucose uptake with ritonavir
por: Jodeleit, Henrika, et al.
Publicado: (2018) -
A mouse model for ulcerative colitis based on NOD-scid IL2R γ(null) mice reconstituted with peripheral blood mononuclear cells from affected individuals
por: Palamides, Pia, et al.
Publicado: (2016) -
NOD/scid IL‐2Rγ(null) mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype
por: Unterweger, Anna‐Lena, et al.
Publicado: (2021) -
CD1a-Expressing Monocytes as Mediators of Inflammation in Ulcerative Colitis
por: Al-amodi, Omar, et al.
Publicado: (2018)